These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 35454904)

  • 21. Multiplex Immunohistochemistry Analysis of Melanoma Tumor-Infiltrating Lymphocytes.
    Nguyen T; Kocovski N; Macdonald S; Yeang HXA; Wang M; Neeson PJ
    Methods Mol Biol; 2021; 2265():557-572. PubMed ID: 33704740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The balance between breast cancer and the immune system: Challenges for prognosis and clinical benefit from immunotherapies.
    Baxevanis CN; Fortis SP; Perez SA
    Semin Cancer Biol; 2021 Jul; 72():76-89. PubMed ID: 31881337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multidimensional profiling depicts infiltrating immune cell heterogeneity in the tumor microenvironment of stage IA non-small cell lung cancer.
    Duan J; Lv G; Zhu N; Chen X; Shao Y; Liu Y; Zhao W; Shi Y
    Thorac Cancer; 2022 Apr; 13(7):947-955. PubMed ID: 35150094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multispectral quantitative immunohistochemical analysis of tumor-infiltrating lymphocytes in relation to programmed death-ligand 1 expression in triple-negative breast cancer.
    Sugie T; Sato E; Miyashita M; Yamaguchi R; Sakatani T; Kozuka Y; Moritani S; Suzuki E; Kakimi K; Mikami Y; Moriya T
    Breast Cancer; 2020 Jul; 27(4):519-526. PubMed ID: 32447649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperspectral cell sociology reveals spatial tumor-immune cell interactions associated with lung cancer recurrence.
    Enfield KSS; Martin SD; Marshall EA; Kung SHY; Gallagher P; Milne K; Chen Z; Nelson BH; Lam S; English JC; MacAulay CE; Lam WL; Guillaud M
    J Immunother Cancer; 2019 Jan; 7(1):13. PubMed ID: 30651131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biomarkers of neoadjuvant/adjuvant chemotherapy for breast cancer.
    Iwamoto T; Kajiwara Y; Zhu Y; Iha S
    Chin Clin Oncol; 2020 Jun; 9(3):27. PubMed ID: 32192349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a multiplex immuno-oncology biomarker and digital pathology workflow for assessment of urothelial carcinoma.
    Xie Y; Olkhov-Mitsel E; Alminawi S; Slodkowska E; Downes MR
    Pathol Res Pract; 2021 Oct; 226():153607. PubMed ID: 34509050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor-infiltrating immune cell profiles and their change after neoadjuvant chemotherapy predict response and prognosis of breast cancer.
    García-Martínez E; Gil GL; Benito AC; González-Billalabeitia E; Conesa MA; García García T; García-Garre E; Vicente V; Ayala de la Peña F
    Breast Cancer Res; 2014 Nov; 16(6):488. PubMed ID: 25432519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined Consideration of Tumor-Associated Immune Cell Density and Immune Checkpoint Expression in the Peritumoral Microenvironment for Prognostic Stratification of Non-Small-Cell Lung Cancer Patients.
    Yang Y; Yang X; Wang Y; Xu J; Shen H; Gou H; Qin X; Jiang G
    Front Immunol; 2022; 13():811007. PubMed ID: 35222387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immuno-profiling and cellular spatial analysis using five immune oncology multiplex immunofluorescence panels for paraffin tumor tissue.
    Parra ER; Ferrufino-Schmidt MC; Tamegnon A; Zhang J; Solis L; Jiang M; Ibarguen H; Haymaker C; Lee JJ; Bernatchez C; Wistuba II
    Sci Rep; 2021 Apr; 11(1):8511. PubMed ID: 33875760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Challenges and Opportunities for Immunoprofiling Using a Spatial High-Plex Technology: The NanoString GeoMx
    Hernandez S; Lazcano R; Serrano A; Powell S; Kostousov L; Mehta J; Khan K; Lu W; Solis LM
    Front Oncol; 2022; 12():890410. PubMed ID: 35847846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiplex Immunofluorescence Assays.
    Francisco-Cruz A; Parra ER; Tetzlaff MT; Wistuba II
    Methods Mol Biol; 2020; 2055():467-495. PubMed ID: 31502166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Tumor Immune Landscape and Architecture of Tertiary Lymphoid Structures in Urothelial Cancer.
    van Dijk N; Gil-Jimenez A; Silina K; van Montfoort ML; Einerhand S; Jonkman L; Voskuilen CS; Peters D; Sanders J; Lubeck Y; Broeks A; Hooijberg E; Vis DJ; van den Broek M; Wessels LFA; van Rhijn BWG; van der Heijden MS
    Front Immunol; 2021; 12():793964. PubMed ID: 34987518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune contexture analysis in immuno-oncology: applications and challenges of multiplex fluorescent immunohistochemistry.
    Shakya R; Nguyen TH; Waterhouse N; Khanna R
    Clin Transl Immunology; 2020; 9(10):e1183. PubMed ID: 33072322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Immune Microenvironment in Breast Carcinoma: Predictive and Prognostic Role in the Neoadjuvant Setting.
    Badr NM; Berditchevski F; Shaaban AM
    Pathobiology; 2020; 87(2):61-74. PubMed ID: 31715606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Machine Learning and Artificial Intelligence-driven Spatial Analysis of the Tumor Immune Microenvironment in Pathology Slides.
    Xu H; Cong F; Hwang TH
    Eur Urol Focus; 2021 Jul; 7(4):706-709. PubMed ID: 34353733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathological response and predictive role of tumour-infiltrating lymphocytes in HER2-positive early breast cancer treated with neoadjuvant pyrotinib plus trastuzumab and chemotherapy (Panphila): a multicentre phase 2 trial.
    Liu Z; Wang C; Chen X; Zhu J; Sun X; Xia Q; Lu Z; Qiao J; Zhou Y; Wang H; Wang Y; Yan M
    Eur J Cancer; 2022 Apr; 165():157-168. PubMed ID: 35235873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor-Infiltrating Lymphocytes in Triple Negative Breast Cancer: The Future of Immune Targeting.
    García-Teijido P; Cabal ML; Fernández IP; Pérez YF
    Clin Med Insights Oncol; 2016; 10(Suppl 1):31-9. PubMed ID: 27081325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploring the spatial dimension of estrogen and progesterone signaling: detection of nuclear labeling in lobular epithelial cells in normal mammary glands adjacent to breast cancer.
    Grote A; Abbas M; Linder N; Kreipe HH; Lundin J; Feuerhake F
    Diagn Pathol; 2014; 9 Suppl 1(Suppl 1):S11. PubMed ID: 25565114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multi-Omics Perspective Reveals the Different Patterns of Tumor Immune Microenvironment Based on Programmed Death Ligand 1 (PD-L1) Expression and Predictor of Responses to Immune Checkpoint Blockade across Pan-Cancer.
    Huang K; Hu M; Chen J; Wei J; Qin J; Lin S; Du H
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34068143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.